BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7830337)

  • 1. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
    Sanchiz F; Milla A
    Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
    Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I study of orally administered UFT plus l-leucovorin].
    Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
    González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
    Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
    Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
    Tashiro H; Nomura Y; Ohsaki A
    Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P
    Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
    Takashima S; Tomita F; Saito H; Gotoda H; Kinami Y; Miyazaki I; Yamaguchi A
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2315-24. PubMed ID: 1929450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.